Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Boston trumps Johnson & Johnson bid again with $27bn offer for Guidant

This article was originally published in Clinica

  • News

Executive Summary

Boston Scientific has hiked its offer for Guidant by nearly $2bn, proposing to pay $27bn for the cardiology firm. The last few days have seen the tug-of-war between Boston and Johnson & Johnson for Guidant intensify with a series of bids and counterbids. The latest volley served by Boston Scientific trumps J&J's most recent bid of $24.2bn, which it made late on Friday (January 13).

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

News We’re Watching: Telehealth Advances; AI Regulation; NIH Backs SIRT; Oura Upgraded

FDA Grants De Novo Marketing Authorization For At-Home Retinal Imaging Device

UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024

Mid-May MDCG Mandate Madness: Pre-empting Questions On Investigator Brochures

See All
UsernamePublicRestriction

Register

MT050684

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By